Study of the Epidemiological, Clinical, Diagnostic, and Therapeutic Characteristics of Gastric Cancers in Algeria
NCT07481110 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 1000
Last updated 2026-03-27
Summary
The goal of this observational study is to describe the demographic, epidemiological, clinical, and outcome characteristics of patients with gastric cancer.
It also aims to analyze the diagnostic approaches and management strategies used in the care of these patients in Algeria.
Conditions
- Gastric Cancer
- Gastric (Stomach) Cancer
- Gastric Cancer (Diagnosis)
Sponsors & Collaborators
- collaborator INDUSTRY
-
ES Clinical Research
collaborator UNKNOWN -
Société Algérienne de Formation et Recherche en Oncologie
lead OTHER
Eligibility
- Min Age
- 19 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-08-05
- Primary Completion
- 2026-08-05
- Completion
- 2026-08-05
Countries
- Algeria
Study Locations
More Related Trials
-
Gastric Cancer Registry for Epidemiology and Molecular Risk Factor
NCT03046745 ·Status: UNKNOWN
-
A Study of Herceptin (Trastuzumab) in Patients With Metastatic or Advanced Gastric Cancer With Disease Progression
NCT02005484 ·Status: TERMINATED ·Phase: PHASE2
-
Investigation of the Proportion of Human Epidermal Growth Factor Receptor 2 Protein Overexpression of Gastric Adenocarcinoma and Prognostic Effect of HER2, and Analysis of Practice Pattern of Herceptin Use in Stage IV Gastric Cancer
NCT02136836 ·Status: UNKNOWN
-
Genomic and Dietary Aspects in Gastric Cancer Risk
NCT05934058 ·Status: NOT_YET_RECRUITING
-
Comparing the Prognosis of Patients With Cardia and Non-cardia Gastric Cancer.
NCT03895008 ·Status: UNKNOWN
-
An Observational Study of Herceptin (Trastuzumab) in Patients With HER2-positive Advanced Gastric Cancer
NCT01220934 ·Status: COMPLETED
-
Prognostic and Predictive Impact of Circulating Tumor DNA in Gastric Cancer Treatment
NCT02674373 ·Status: UNKNOWN
-
Study of TAS-102 or Placebo Plus BSC in Patients With Metastatic Gastric Cancer
NCT02500043 ·Status: COMPLETED ·Phase: PHASE3
-
Cohort of Well-differentiated Grade 3 Neuroendocrine Digestive Tumors
NCT04365023 ·Status: COMPLETED
-
Predictive Factors of Morbidity and Mortality and Overall Survival of Patients With Gastric Cancer : a Case Series
NCT05186402 ·Status: COMPLETED
-
Efficacy of Irinotecan and Capecitabine Versus(vs) Cisplatin and Capecitabine in Patients With Esophago-Gastric Cancer
NCT00675194 ·Status: COMPLETED ·Phase: PHASE2
-
A Non-Interventional Study of Treatment Pattern and Clinical Outcomes in Chinese Participants With Gastric Cancer
NCT01839500 ·Status: COMPLETED
-
Clinical Study to Evaluate the Safety and Anti-Tumor Activity of AB-201
NCT07333820 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1
-
A Study to Evaluate Rivoceranib Plus Best Supportive Care Compared to Placebo Plus Best Supportive Care in Participants With Gastric Cancer
NCT03042611 ·Status: COMPLETED ·Phase: PHASE3
-
Artificial Intelligence and Cancer Staging in Upper Gastrointestinal Malignancies
NCT05648084 ·Status: COMPLETED
-
Phase II Study of Neoadjuvant Taxotere, Cisplatin, and 5-Fluorouracil in Patients With Gastric or Gastroesophageal Junction Adenocarcinoma
NCT00763646 ·Status: UNKNOWN ·Phase: PHASE2
-
Dissecting the Role of MIcrobioMe in gastroEsophageal Tumor: a multIdisCiplinary Longitudinal Study
NCT06405035 ·Status: RECRUITING
-
S-1 Combined Cisplatin HIPEC for Palliative Operation Gastric Cancer of Stage IV Limited Peritoneal Metastasis
NCT02291211 ·Status: UNKNOWN ·Phase: PHASE2
-
Prediction of Neoadjuvant Chemotherapy Efficacy in Locally Advanced Gastric Cancer
NCT05140746 ·Status: RECRUITING ·Phase: NA
-
Study of DP303c Injection in Patients With Advanced or Metastatic Gastric Cancer
NCT04826107 ·Status: UNKNOWN ·Phase: PHASE2
-
Improving the Approach to and Management of the Older Patient With Metastatic Gastric Cancer
NCT04618809 ·Status: UNKNOWN ·Phase: NA
-
Peritoneal Lavage Liquid Biopsy in Patients With Gastric Cancer
NCT04943406 ·Status: RECRUITING
-
Relationship Between Standard Treatment Efficacy and The Tumor Microenvironment in Advanced Gastric Cancer
NCT04850716 ·Status: UNKNOWN
-
BReast CAncer Genes(BRCA) Expressions in Metastatic Gastric Cancer
NCT03838406 ·Status: COMPLETED ·Phase: NA
-
Phase II Study of DC Versus 5-FU/CF as Chemotherapy and Concurrent Chemoradiotherapy for Locally Advanced Gastric Cancer
NCT01889303 ·Status: UNKNOWN ·Phase: PHASE2